Quest Diagnostics Incorporated
DGX
$195.23
-$3.38-1.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -13.12% | 28.18% | -0.90% | -1.77% |
| Total Depreciation and Amortization | 2.11% | -0.70% | 2.14% | 3.70% | 8.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.90% | 142.19% | 45.45% | -40.54% | 57.45% |
| Change in Net Operating Assets | 204.76% | -61.82% | 161.11% | -372.73% | 178.57% |
| Cash from Operations | -17.41% | 3.49% | 73.25% | -32.33% | 30.34% |
| Capital Expenditure | -9.72% | -33.33% | 7.69% | 4.88% | -16.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -47.06% | -100.00% | -- | -- | 75.02% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 173.91% | -2,400.00% | -50.00% | -50.00% | -33.33% |
| Cash from Investing | 4.98% | -62.10% | -7.83% | 77.09% | 69.26% |
| Total Debt Issued | -100.00% | -94.59% | -13.95% | -- | -100.00% |
| Total Debt Repaid | 90.00% | 97.51% | 33.17% | -59,900.00% | 0.00% |
| Issuance of Common Stock | -5.26% | 46.15% | -55.17% | 38.10% | -12.50% |
| Repurchase of Common Stock | -98.03% | -- | 100.00% | 72.19% | -15,000.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.12% | 1.11% | -7.14% | 0.00% | 0.00% |
| Other Financing Activities | 448.00% | -- | 100.00% | -275.56% | 421.43% |
| Cash from Financing | -16.19% | 15.70% | 47.77% | -230.00% | -109.60% |
| Foreign Exchange rate Adjustments | 150.00% | -150.00% | 300.00% | 114.29% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.62% | -13.74% | 136.29% | -67.91% | -143.61% |